Search result for 'medicine prices'

Delhi traders give mixed reactions to the Union Budget 2026-27, citing both positive and negative aspects for various sectors.

Bulk drug makers urge Centre to expedite MIP implementation to combat predatory Chinese pricing. MIP is a stabilisation tool, not a trade barrier.

Natco Pharma to acquire significant stakes in South African pharmaceutical firm Adcock Ingram. Deal details and market impact.

Congress MP Manickam Tagore has written to PM Modi expressing concern over the recent price hike of 8 essential drugs. He seeks an independent review committee to assess the impact.

Union Minister Mansukh Mandaviya assures no increase in essential medicine prices this fiscal year due to negligible inflation. The NPPA has approved a minimal WPI increase, leading to almost no...

GTRI report highlights India's stance on intellectual property rights (IPRs) and pharma issues in trade pacts, balancing innovation with public health needs and promoting generic drug industry growth.

The Indian government aims to have 25,000 Janaushadhi Kendras across the country by March 2026, offering affordable medicines to citizens. The scheme aims to provide affordable healthcare options.